相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epidemiology of chronic liver diseases in the USA in the past three decades
Zobair M. Younossi et al.
GUT (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetes
Oscar Chavez-Talavera et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort
Quentin M. Anstee et al.
JOURNAL OF HEPATOLOGY (2020)
Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?
Oscar Chavez-Talavera et al.
CURRENT OPINION IN LIPIDOLOGY (2019)
Fasting serum bile acids concentration is associated with insulin resistance independently of diabetes status
Sang-Guk Lee et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients
Daniel Margerie et al.
BMC MEDICAL GENOMICS (2019)
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2019)
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
Norbert Stefan et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi et al.
LANCET (2019)
Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
Na Jiao et al.
GUT (2018)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
Puneet Puri et al.
HEPATOLOGY (2018)
Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
Oscar Chavez-Talavera et al.
GASTROENTEROLOGY (2017)
Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects
Vanessa Legry et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Incidence and Predictive Factors of Postprandial Hyperinsulinemic Hypoglycemia After Roux-en-Y Gastric Bypass: A Five year Longitudinal Study
Violeta Raverdy et al.
ANNALS OF SURGERY (2016)
Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
Joel T. Haas et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 78 (2016)
Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes
David P. Sonne et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
Brian C. Ferslew et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Plasma bile acids show a positive correlation with body mass index and are negatively associated with cognitive restraint of eating in obese patients
Philip Prinz et al.
FRONTIERS IN NEUROSCIENCE (2015)
Loss of Cyp8b1 Improves Glucose Homeostasis by Increasing GLP-1
Achint Kaur et al.
DIABETES (2015)
Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding to Reduce Nonalcoholic Fatty Liver Disease A 5-Year Controlled Longitudinal Study
Robert Caiazzo et al.
ANNALS OF SURGERY (2014)
Beyond intestinal soap-bile acids in metabolic control
Folkert Kuipers et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
Higher circulating bile acid concentrations in obese patients with type 2 diabetes
Royce P. Vincent et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2013)
Plasma metabolomic profile in nonalcoholic fatty liver disease
Satish C. Kalhan et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2010)
Glucose stimulates cholesterol 7α-hydroxylase gene transcription in human hepatocytes
Tiangang Li et al.
JOURNAL OF LIPID RESEARCH (2010)
Plasma bile acids are not associated with energy metabolism in humans
Gemma Brufau et al.
NUTRITION & METABOLISM (2010)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Glucose regulates the expression of the farnesoid X receptor in liver
D Duran-Sandoval et al.
DIABETES (2004)
分享论文
